These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7332587)

  • 1. Vitamin K epoxide reductase: evidence that vitamin K dihydroquinone is a product of vitamin K epoxide reduction.
    Sherman PA; Sander EG
    Biochem Biophys Res Commun; 1981 Dec; 103(3):997-1005. PubMed ID: 7332587
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
    Wallin R; Patrick SD; Martin LF
    Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is thioredoxin the physiological vitamin K epoxide reducing agent?
    Preusch PC
    FEBS Lett; 1992 Jul; 305(3):257-9. PubMed ID: 1299627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
    Fasco MJ; Principe LM
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1487-92. PubMed ID: 7213374
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
    Preusch PC; Suttie JW
    Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect inhibition of vitamin K epoxide reduction by salicylate.
    Hildebrandt E; Suttie JW
    J Pharm Pharmacol; 1984 Sep; 36(9):586-91. PubMed ID: 6149281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
    Mukharji I; Silverman RB
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G; Labrecque G; Bélanger PM
    Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
    Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
    J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
    J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
    Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted vitamin K epoxide analogues. New competitive inhibitors and substrates of vitamin K1 epoxide reductase.
    Ryall RP; Nandi DL; Silverman RB
    J Med Chem; 1990 Jun; 33(6):1790-7. PubMed ID: 2342073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.